Daculsi Guy
INSERM U791, Laboratory for Osteoarticular and Dental Tissue Engineering, Dental Faculty, Nantes University, Place A. Ricordeau, 44042, Nantes, France,
J Mater Sci Mater Med. 2015 Apr;26(4):154. doi: 10.1007/s10856-015-5482-7. Epub 2015 Mar 17.
The commercial offer for bioceramic bone substitutes is very large, however, the prerequisites for applications in bone reconstruction and tissue engineering, are most often absent. The main criteria being: on the one hand physico-chemical features providing surgeons with an injectable and/or shapeable biomaterial; on the second hand the multi-scale bioactivity leading to osteoconduction and osteoinduction properties. In order to obtain greater suitability according to the nature of the bone defect to be treated, new bone regeneration technologies, "smart scaffolds" must be developed and optimize to support suitable Ortho Biology.
生物陶瓷骨替代物的商业供应规模很大,然而,在骨重建和组织工程中的应用前提条件却往往缺失。主要标准如下:一方面是物理化学特性,要能为外科医生提供可注射和/或可塑形的生物材料;另一方面是多尺度生物活性,可带来骨传导和骨诱导特性。为了根据待治疗骨缺损的性质获得更高的适用性,必须开发并优化新的骨再生技术,即“智能支架”,以支持合适的骨生物学。